MGRX vs. BRTX, GBNHF, OTRK, SONX, PBM, IBIO, TTNP, CELZ, ENVB, and SHPH
Should you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include BioRestorative Therapies (BRTX), Greenbrook TMS (GBNHF), Ontrak (OTRK), Sonendo (SONX), Psyence Biomedical (PBM), iBio (IBIO), Titan Pharmaceuticals (TTNP), Creative Medical Technology (CELZ), Enveric Biosciences (ENVB), and Shuttle Pharmaceuticals (SHPH). These companies are all part of the "medical" sector.
BioRestorative Therapies (NASDAQ:BRTX) and Mangoceuticals (NASDAQ:MGRX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, community ranking, media sentiment, institutional ownership, dividends, valuation and risk.
Mangoceuticals has a net margin of -1,260.81% compared to Mangoceuticals' net margin of -9,873.97%. Mangoceuticals' return on equity of -114.84% beat BioRestorative Therapies' return on equity.
BioRestorative Therapies and Mangoceuticals both received 0 outperform votes by MarketBeat users.
Mangoceuticals has higher revenue and earnings than BioRestorative Therapies.
In the previous week, BioRestorative Therapies had 5 more articles in the media than Mangoceuticals. MarketBeat recorded 7 mentions for BioRestorative Therapies and 2 mentions for Mangoceuticals. BioRestorative Therapies' average media sentiment score of 1.28 beat Mangoceuticals' score of -0.08 indicating that Mangoceuticals is being referred to more favorably in the news media.
69.4% of BioRestorative Therapies shares are held by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are held by institutional investors. 21.6% of BioRestorative Therapies shares are held by insiders. Comparatively, 46.4% of Mangoceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
BioRestorative Therapies and Mangoceuticals tied by winning 5 of the 10 factors compared between the two stocks.
Get Mangoceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Mangoceuticals Competitors List
Related Companies and Tools
